Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2013 (2013), Article ID 243934, 10 pages
http://dx.doi.org/10.1155/2013/243934
Review Article

Role of Vitamin D in Cardiometabolic Diseases

Department of Endocrinology, Shanghai Pudong Hospital, 2800 Gongwei Road, Huinan Town, Pudong, Shanghai 201399, China

Received 23 November 2012; Revised 9 January 2013; Accepted 9 January 2013

Academic Editor: T. S. Kern

Copyright © 2013 Chaoxun Wang. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. D. Bikle, “Vitamin D: newly discovered actions require reconsideration of physiologic requirements,” Trends in Endocrinology and Metabolism, vol. 21, no. 6, pp. 375–384, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. M. F. Holick, “Vitamin D deficiency,” The New England Journal of Medicine, vol. 357, pp. 266–281, 2007. View at Google Scholar
  3. E. Stivelman and R. Retnakaran, “Role of vitamin D in the pathophysiology and treatment of type 2 diabetes,” Current Diabetes Reviews, vol. 8, pp. 42–47, 2012. View at Google Scholar
  4. B. Dawson-Hughes, A. Mithal, J. P. Bonjour et al., “IOF position statement: vitamin D recommendations for older adults,” Osteoporosis International, vol. 21, no. 7, pp. 1151–1154, 2010. View at Google Scholar · View at Scopus
  5. M. L. Stroud, S. Stilgoe, V. E. Stott, O. Alhabian, and K. Salman, “Vitamin D—a review,” Australian Family Physician, vol. 37, no. 12, pp. 1002–1005, 2008. View at Google Scholar · View at Scopus
  6. M. C. Chapuy, P. Preziosi, M. Maamer et al., “Prevalence of vitamin D insufficiency in an adult normal population,” Osteoporosis International, vol. 7, no. 5, pp. 439–443, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. M. B. Snijder, R. M. van Dam, M. Visser et al., “Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 7, pp. 4119–4123, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Ovesen, R. Andersen, and J. Jakobsen, “Geographical differences in vitamin D status, with particular reference to European countries,” Proceedings of the Nutrition Society, vol. 62, no. 4, pp. 813–821, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Lips, “Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications,” Endocrine Reviews, vol. 22, no. 4, pp. 477–501, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. A. C. Looker, B. Dawson-Hughes, M. S. Calvo, E. W. Gunter, and N. R. Sahyoun, “Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III,” Bone, vol. 30, no. 5, pp. 771–777, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Lips, D. Hosking, K. Lippuner et al., “The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation,” Journal of Internal Medicine, vol. 260, no. 3, pp. 245–254, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. S. K. Lim, A. W. C. Kung, S. Sompongse, S. Soontrapa, and K. S. Tsai, “Vitamin D inadequacy in postmenopausal women in Eastern Asia,” Current Medical Research and Opinion, vol. 24, no. 1, pp. 99–106, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Mithal, D. A. Wahl, J. P. Bonjour et al., “Global vitamin D status and determinants of hypovitaminosis D,” Osteoporosis International, vol. 20, no. 11, pp. 1807–1820, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. Institute of Medicine, Food and Nutrition Board, Dietary Reference Intakes For Calcium and Vitamin D, National Academy Press, Washington, DC, USA, 2010.
  15. P. Hodgkin, G. H. Kay, P. M. Hine, G. A. Lumb, and S. W. Stanbury, “Vitamin D deficiency in Asians at home and in Britain,” The Lancet, vol. 2, no. 7822, pp. 167–171, 1973. View at Google Scholar · View at Scopus
  16. R. Goswami, N. Gupta, D. Goswami, R. K. Marwaha, N. Tandon, and N. Kochupillai, “Prevalence and significance of low 25-hydroxyvitamin D concentrations in healthy subjects in Delhi,” The American Journal of Clinical Nutrition, vol. 72, no. 2, pp. 472–475, 2000. View at Google Scholar · View at Scopus
  17. V. Arya, R. Bhambri, M. M. Godbole, and A. Mithal, “Vitamin D status and its relationship with bone mineral density in healthy Asian Indians,” Osteoporosis International, vol. 15, no. 1, pp. 56–61, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Sachan, R. Gupta, V. Das, A. Agarwal, P. K. Awasthi, and V. Bhatia, “High prevalence of vitamin D deficiency among pregnant women and their newborns in northern India,” The American Journal of Clinical Nutrition, vol. 81, no. 5, pp. 1060–1064, 2005. View at Google Scholar · View at Scopus
  19. C. V. Harinarayan, T. Ramalakshmi, U. V. Prasad et al., “High prevalence of low dietary calcium, high phytate consumption, and vitamin D deficiency in healthy south Indians,” The American Journal of Clinical Nutrition, vol. 85, no. 4, pp. 1062–1067, 2007. View at Google Scholar · View at Scopus
  20. R. Zhang and D. P. Naughton, “Vitamin D in health and disease: current perspectives,” Nutrition Journal, vol. 9, no. 1, article 65, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. A. G. Need, H. A. Morris, M. Horowitz, and B. E. C. Nordin, “Effects of skin thickness, age, body fat, and sunlight on serum 25- hydroxyvitamin D,” The American Journal of Clinical Nutrition, vol. 58, no. 6, pp. 882–885, 1993. View at Google Scholar · View at Scopus
  22. T. L. Clemens, J. S. Adams, S. L. Henderson, and M. F. Holick, “Increased skin pigment reduces the capacity of skin to synthesise vitamin D3,” The Lancet, vol. 1, no. 8263, pp. 74–76, 1982. View at Google Scholar · View at Scopus
  23. L. Y. Matsuoka, L. Ide, J. Wortsman, J. A. MacLaughlin, and M. F. Holick, “Sunscreens suppress cutaneous vitamin D3 synthesis,” Journal of Clinical Endocrinology and Metabolism, vol. 64, no. 6, pp. 1165–1168, 1987. View at Google Scholar · View at Scopus
  24. A. M. Pack and M. J. Morrell, “Epilepsy and bone health in adults,” Epilepsy and Behavior, vol. 5, supplement 2, pp. S24–S29, 2004. View at Google Scholar · View at Scopus
  25. S. C. Shah, R. K. Sharma, Hemangini, and A. R. Chitle, “Rifampicin induced osteomalacia,” Tubercle, vol. 62, no. 3, pp. 207–209, 1981. View at Google Scholar · View at Scopus
  26. C. J. P. Van Den Bout-Van Den Beukel, L. Fievez, M. Michels et al., “Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: effects of antiretroviral therapy,” AIDS Research and Human Retroviruses, vol. 24, no. 11, pp. 1375–1382, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Liel, E. Ulmer, J. Shary, B. W. Hollis, and N. H. Bell, “Low circulating vitamin D in obesity,” Calcified Tissue International, vol. 43, no. 4, pp. 199–201, 1988. View at Google Scholar · View at Scopus
  28. L. Hyldstrup, T. Andersen, P. McNair, L. Breum, and I. Transbol, “Bone metabolism in obesity: changes related to severe overweight and dietary weight reduction,” Acta Endocrinologica, vol. 129, no. 5, pp. 393–398, 1993. View at Google Scholar · View at Scopus
  29. J. Wortsman, L. Y. Matsuoka, T. C. Chen, Z. Lu, and M. F. Holick, “Decreased bioavailability of vitamin D in obesity,” The American Journal of Clinical Nutrition, vol. 72, no. 3, pp. 690–693, 2000. View at Google Scholar · View at Scopus
  30. C. McGreevy and D. Williams, “New insights about vitamin D and cardiovascular disease,” Annals of Internal Medicine, vol. 155, pp. 820–826, 2011. View at Google Scholar
  31. H. F. DeLuca, “Overview of general physiologic features and functions of vitamin D,” The American Journal of Clinical Nutrition, vol. 80, no. 6, supplement, pp. 1689S–1696S, 2004. View at Google Scholar
  32. M. Garabedian, Y. Tanaka, M. F. Holick, and H. F. Deluca, “Response of intestinal calcium transport and bone calcium mobilization to 1,25 dihydroxyvitamin D3 in thyroparathyroidectomized rats,” Endocrinology, vol. 94, no. 4, pp. 1022–1027, 1974. View at Google Scholar · View at Scopus
  33. M. Yamamoto, Y. Kawanobe, H. Takahashi, E. Shimazawa, S. Kimura, and E. Ogata, “Vitamin D deficiency and renal calcium transport in the rat,” The Journal of Clinical Investigation, vol. 74, pp. 507–513, 1984. View at Google Scholar
  34. D. Shoback, D. Sellmeyer, and D. Bikle, Greenspan’s Basic and Clinical Endocrinology, McGraw-Hill, Columbus, Ohio, USA, 8th edition, 2007.
  35. M. F. Holick, “Vitamin D: a millenium perspective,” Journal of Cellular Biochemistry, vol. 88, no. 2, pp. 296–307, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. S. R. Motiwala and T. J. Wang, “Vitamin D and cardiovascular risk,” Current Hypertension Reports, vol. 14, pp. 209–218, 2012. View at Google Scholar
  37. R. E. Weishaar and R. U. Simpson, “Vitamin D3 and cardiovascular function in rats,” The Journal of Clinical Investigation, vol. 79, pp. 1706–1712, 1987. View at Google Scholar
  38. C. W. Park, Y. S. Oh, Y. S. Shin et al., “Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism,” American Journal of Kidney Diseases, vol. 33, no. 1, pp. 73–81, 1999. View at Google Scholar · View at Scopus
  39. T. Shoji, K. Shinohara, E. Kimoto et al., “Lower risk for cardiovascular mortality in oral 1α-hydroxy vitamin D3 users in a haemodialysis population,” Nephrology Dialysis Transplantation, vol. 19, no. 1, pp. 179–184, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. S. G. Rostand and T. B. Drüeke, “Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure,” Kidney International, vol. 56, no. 2, pp. 383–392, 1999. View at Publisher · View at Google Scholar · View at Scopus
  41. D. Duprez, M. De Buyzere, T. De Backer, and D. Clement, “Relationship between vitamin D3 and the peripheral circulation in moderate arterial primary hypertension,” Blood Pressure, vol. 3, no. 6, pp. 389–393, 1994. View at Google Scholar · View at Scopus
  42. R. Scragg, I. Holdaway, V. Singh, P. Metcalf, J. Baker, and E. Dryson, “Serum 25-hydroxycholecalciferol concentration in newly detected hypertension,” American Journal of Hypertension, vol. 8, no. 4, pp. 429–432, 1995. View at Google Scholar · View at Scopus
  43. R. Scragg, M. F. Sowers, and C. Bell, “Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the third national health and nutrition examination survey,” American Journal of Hypertension, vol. 20, no. 7, pp. 713–719, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. J. P. Forman, E. Giovannucci, M. D. Holmes et al., “Plasma 25-hydroxyvitamin D levels and risk of incident hypertension,” Hypertension, vol. 49, no. 5, pp. 1063–1069, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. S. K. Bhandari, S. Pashayan, I. L. A. Liu et al., “25-Hydroxyvitamin D levels and hypertension rates,” Journal of Clinical Hypertension, vol. 13, no. 3, pp. 170–177, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Pfeifer, B. Begerow, H. W. Minne, D. Nachtigall, and C. Hansen, “Effects of a short-term vitamin D3 and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 4, pp. 1633–1637, 2001. View at Publisher · View at Google Scholar · View at Scopus
  47. J. A. Sugden, J. I. Davies, M. D. Witham, A. D. Morris, and A. D. Struthers, “Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels,” Diabetic Medicine, vol. 25, no. 3, pp. 320–325, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. K. L. Margolis, R. M. Ray, L. Van Horn et al., “Effect of calcium and vitamin D supplementation on blood pressure: the women's health initiative randomized trial,” Hypertension, vol. 52, no. 5, pp. 847–855, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. A. G. Pittas, M. Chung, T. Trikalinos et al., “Systematic review: vitamin D and cardiometabolic outcomes,” Annals of Internal Medicine, vol. 152, no. 5, pp. 307–314, 2010. View at Google Scholar · View at Scopus
  50. M. L. Melamed, P. Muntner, E. D. Michos et al., “Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease results from NHANES 2001 to 2004,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 6, pp. 1179–1185, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. B. Lund, J. Badskjaer, B. J. Lund, and O. H. Soerensen, “Vitamin D and ischaemic heart disease,” Hormone and Metabolic Research, vol. 10, no. 6, pp. 553–556, 1978. View at Google Scholar · View at Scopus
  52. H. Schmidt Gayk, J. Goossen, F. Lendle, and D. Seidel, “Serum 25 hydroxycalciferol in myocardial infarction,” Atherosclerosis, vol. 26, no. 1, pp. 55–58, 1977. View at Google Scholar · View at Scopus
  53. E. Giovannucci, Y. Liu, B. W. Hollis, and E. B. Rimm, “25-Hydroxyvitamin D and risk of myocardial infarction in men: a prospective study,” Archives of Internal Medicine, vol. 168, no. 11, pp. 1174–1180, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Cigolini, M. P. Iagulli, V. Miconi, M. Galiotto, S. Lombardi, and G. Targher, “Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients,” Diabetes Care, vol. 29, no. 3, pp. 722–724, 2006. View at Google Scholar · View at Scopus
  55. T. J. Wang, M. J. Pencina, S. L. Booth et al., “Vitamin D deficiency and risk of cardiovascular disease,” Circulation, vol. 117, no. 4, pp. 503–511, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. J. Hsia, G. Heiss, H. Ren et al., “Calcium/vitamin D supplementation and cardiovascular events,” Circulation, vol. 115, no. 7, pp. 846–854, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. S. P. Laguardia, B. K. Dockery, S. K. Bhattacharya, M. D. Nelson, L. D. Carbone, and K. T. Weber, “Secondary hyperparathyroidism and hypovitaminosis D in African-Americans with decompensated heart failure,” American Journal of the Medical Sciences, vol. 332, no. 3, pp. 112–118, 2006. View at Publisher · View at Google Scholar · View at Scopus
  58. A. Zittermann, S. S. Schleithoff, G. Tenderich, H. K. Berthold, R. Körfer, and P. Stehle, “Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure?” Journal of the American College of Cardiology, vol. 41, no. 1, pp. 105–112, 2003. View at Publisher · View at Google Scholar · View at Scopus
  59. A. Zittermann, S. S. Schleithoff, C. Götting et al., “Poor outcome in end-stage heart failure patients with low circulating calcitriol levels,” European Journal of Heart Failure, vol. 10, no. 3, pp. 321–327, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Pilz, W. März, B. Wellnitz et al., “Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 10, pp. 3927–3935, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. S. S. Schleithoff, A. Zittermann, G. Tenderich, H. K. Berthold, P. Stehle, and R. Koerfer, “Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial,” The American Journal of Clinical Nutrition, vol. 83, no. 4, pp. 754–759, 2006. View at Google Scholar · View at Scopus
  62. R. Bland, D. Markovic, C. E. Hills et al., “Expression of 25-hydroxyvitamin D3-1α-hydroxylase in pancreatic islets,” Journal of Steroid Biochemistry and Molecular Biology, vol. 89-90, pp. 121–125, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. A. W. Norman, “Minireview: vitamin D receptor: new assignments for an already busy receptor,” Endocrinology, vol. 147, no. 12, pp. 5542–5548, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. J. Y. Oh and E. Barrett-Connor, “Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community-dwelling older adults: The Rancho Bernardo study,” Metabolism, vol. 51, no. 3, pp. 356–359, 2002. View at Publisher · View at Google Scholar · View at Scopus
  65. U. Zeitz, K. Weber, D. W. Soegiarto, E. Wolf, R. Balling, and R. G. Erben, “Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor,” The FASEB Journal, vol. 17, no. 3, pp. 509–511, 2003. View at Google Scholar · View at Scopus
  66. T. Takiishi, C. Gysemans, R. Bouillon, and C. Mathieu, “Vitamin D and diabetes,” Rheumatic Disease Clinics of North America, vol. 38, no. 1, pp. 179–206, 2012. View at Google Scholar
  67. G. Zhao, E. S. Ford, and C. Li, “Associations of serum concentrations of 25-hydroxyvitamin D and parathyroid hormone with surrogate markers of insulin resistance among U.S. adults without physician-diagnosed diabetes: NHANES, 2003–2006,” Diabetes Care, vol. 33, no. 2, pp. 344–347, 2010. View at Publisher · View at Google Scholar · View at Scopus
  68. C. Dalgard, M. Skaalum Petersen, P. Weihe, and P. Grandjean, “Vitamin D status in relation to glucose metabolism in septuagenarians,” Diabetes Care, vol. 34, pp. 1284–1288, 2011. View at Google Scholar
  69. N. G. Forouhi, J. Luan, A. Cooper, B. J. Boucher, and N. J. Wareham, “Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance the medical research council ely prospective study 1990–2000,” Diabetes, vol. 57, no. 10, pp. 2619–2625, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. P. Knekt, M. Laaksonen, C. Mattila et al., “Serum vitamin D and subsequent occurrence of type 2 diabetes,” Epidemiology, vol. 19, pp. 666–671, 2008. View at Google Scholar
  71. J. Nagpal, J. N. Pande, and A. Bhartia, “A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men,” Diabetic Medicine, vol. 26, no. 1, pp. 19–27, 2009. View at Publisher · View at Google Scholar · View at Scopus
  72. P. R. Von Hurst, W. Stonehouse, and J. Coad, “Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient-a randomised, placebo-controlled trial,” British Journal of Nutrition, vol. 103, no. 4, pp. 549–555, 2010. View at Publisher · View at Google Scholar · View at Scopus
  73. B. J. Boucher, N. Mannan, K. Noonan, C. N. Hales, and S. J. W. Evans, “Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in East London Asians,” Diabetologia, vol. 38, no. 10, pp. 1239–1245, 1995. View at Publisher · View at Google Scholar · View at Scopus
  74. A. M. Borissova, T. Tankova, G. Kirilov, L. Dakovska, and R. Kovacheva, “The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients,” International Journal of Clinical Practice, vol. 57, no. 4, pp. 258–261, 2003. View at Google Scholar · View at Scopus
  75. K. Tai, A. G. Need, M. Horowitz, and I. M. Chapman, “Glucose tolerance and vitamin D: effects of treating vitamin D deficiency,” Nutrition, vol. 24, no. 10, pp. 950–956, 2008. View at Publisher · View at Google Scholar · View at Scopus
  76. R. Jorde and Y. Figenschau, “Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels,” European Journal of Nutrition, vol. 48, no. 6, pp. 349–354, 2009. View at Publisher · View at Google Scholar · View at Scopus
  77. M. D. Witham, F. J. Dove, M. Dryburgh, J. A. Sugden, A. D. Morris, and A. D. Struthers, “The effect of different doses of vitamin D3 on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial,” Diabetologia, vol. 53, no. 10, pp. 2112–2119, 2010. View at Publisher · View at Google Scholar · View at Scopus
  78. G. N. Thomas, B. ó Hartaigh, J. A. Bosch et al., “Vitamin D levels predict all-cause and cardiovascular disease mortality in subjects with the metabolic syndrome: the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study,” Diabetes Care, vol. 35, no. 5, pp. 1158–1164, 2012. View at Google Scholar
  79. C. Gagnon, Z. X. Lu, D. J. Magliano et al., “Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab),” Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 6, pp. 1953–1961, 2012. View at Google Scholar
  80. S. Samina Riaz and D. R. Tomlinson, “Pharmacological modulation of nerve growth factor synthesis: a mechanistic comparison of vitamin D receptor and β2-adrenoceptor agonists,” Molecular Brain Research, vol. 85, no. 1-2, pp. 179–188, 2000. View at Publisher · View at Google Scholar · View at Scopus
  81. S. Riaz, M. Malcangio, M. Miller, and D. R. Tomlinson, “A vitamin D3 derivative (CB1093) induces nerve growth factor and prevents neurotrophic deficits in streptozotocin-diabetic rats,” Diabetologia, vol. 42, no. 11, pp. 1308–1313, 1999. View at Publisher · View at Google Scholar · View at Scopus
  82. P. Valensi, C. Le Devehat, J. L. Richard et al., “A multicenter, double-blind, safety study of QR-333 for the treatment of symptomatic diabetic peripheral neuropathy: a preliminary report,” Journal of Diabetes and its Complications, vol. 19, no. 5, pp. 247–253, 2005. View at Publisher · View at Google Scholar · View at Scopus
  83. P. Lee and R. Chen, “Vitamin D as an analgesic for patients with type 2 diabetes and neuropathic pain,” Archives of Internal Medicine, vol. 168, no. 7, pp. 771–772, 2008. View at Publisher · View at Google Scholar · View at Scopus
  84. D. Shehab, K. Al-Jarallah, O. A. Mojiminiyi, H. Al Mohamedy, and N. A. Abdella, “Does vitamin D deficiency play a role in peripheral neuropathy in Type 2 diabetes?” Diabetic Medicine, vol. 29, no. 1, pp. 43–49, 2012. View at Google Scholar
  85. Z. Zhang, L. Sun, Y. Wang et al., “Renoprotective role of the vitamin D receptor in diabetic nephropathy,” Kidney International, vol. 73, no. 2, pp. 163–171, 2008. View at Publisher · View at Google Scholar · View at Scopus
  86. U. Schwarz, K. Amann, S. R. Orth, A. Simonaviciene, S. Wessels, and E. Ritz, “Effect of 1,25(OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats,” Kidney International, vol. 53, no. 6, pp. 1696–1705, 1998. View at Publisher · View at Google Scholar · View at Scopus
  87. R. Agarwal, “Vitamin D, proteinuria, diabetic nephropathy, and progression of CKD,” Clinical Journal of the American Society of Nephrology, vol. 4, no. 9, pp. 1523–1528, 2009. View at Publisher · View at Google Scholar · View at Scopus
  88. V. A. Diaz, A. G. Mainous III, P. J. Carek, A. M. Wessell, and C. J. Everett, “The association of vitamin D deficiency and insufficiency with diabetic nephropathy: implications for health disparities,” Journal of the American Board of Family Medicine, vol. 22, no. 5, pp. 521–527, 2009. View at Publisher · View at Google Scholar · View at Scopus
  89. N. B. Khazai, G. R. Beck Jr., and G. E. Umpierrez, “Diabetes and fractures: an overshadowed association,” Current Opinion in Endocrinology, Diabetes and Obesity, vol. 16, no. 6, pp. 435–445, 2009. View at Publisher · View at Google Scholar · View at Scopus